Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.55 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 6/20 | 0.46 |
| ▸ | MAOB | P27338 | 6/20 | 0.46 |
| ▸ | KDM1A | O60341 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15590483 | 1.00 | AKR1C3 (0.55) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL7352068 | 0.88 | KCNQ3 (0.53) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL4522521 | 0.88 | KCNQ3 (0.53) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL7352063 | 0.88 | KCNQ3 (0.53) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL12354198 | 0.88 | KCNQ3 (0.56) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL12592455 | 0.88 | KCNQ3 (0.53) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL838634 | 0.88 | KCNQ3 (0.56) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL22492058 | 0.88 | KCNQ3 (0.56) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL22492062 | 0.88 | KCNQ3 (0.56) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 | |
| SCHEMBL839092 | 0.88 | KCNQ3 (0.53) | AKR1C3AKR1C1HDAC4FFAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120554213-A | Synthesis method of 2-phenylcyclobutane-1-formic acid | 南京工业大学 | 2025-08-29 | — | — | CN | disclosed |
| CN-120554213-A | Synthesis method of 2-phenylcyclobutane-1-formic acid | 南京工业大学 | 2025-08-29 | — | — | CN | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| CN-1988955-B | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO | 2010-09-29 | — | — | CN | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| CN-1988955-A | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL CO (JP) | 2007-06-27 | — | — | CN | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | AKR1C3 127/4885AKR1C1 178/4885HDAC4 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.